SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-008805
Filing Date
2023-05-09
Accepted
2023-05-09 16:05:27
Documents
14
Period of Report
2023-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K omer-20230509x8k.htm   iXBRL 8-K 35338
2 EX-99.1 omer-20230509xex99d1.htm EX-99.1 175317
3 GRAPHIC omer-20230509xex99d1001.jpg GRAPHIC 5215
  Complete submission text file 0001558370-23-008805.txt   354118

Data Files

Seq Description Document Type Size
4 EX-101.SCH omer-20230509.xsd EX-101.SCH 3352
5 EX-101.LAB omer-20230509_lab.xml EX-101.LAB 15359
6 EX-101.PRE omer-20230509_pre.xml EX-101.PRE 10390
8 EXTRACTED XBRL INSTANCE DOCUMENT omer-20230509x8k_htm.xml XML 4618
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 23901885
SIC: 2834 Pharmaceutical Preparations